Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jiqi Shan"'
Autor:
Congcong Li, Zhen Zhang, Qianfeng Cai, Qitai Zhao, Han Wu, JunRu Li, Yaqing Liu, Xuan Zhao, Jinyan Liu, Yu Ping, Jiqi Shan, Shengli Yang, Yi Zhang
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
ABSTRACTIdentifying tumor-relevant T cell subsets in the peripheral blood (PB) has become a potential strategy for cancer treatment. However, the subset of PB that could be used to treat cancer remains poorly defined. Here, we found that the CX3CR1+
Externí odkaz:
https://doaj.org/article/86f7944fe50d4da3ada83ee190cde383
Autor:
Jiqi Shan, Wei Jing, Yu Ping, Chunyi Shen, Dong Han, Fengsen Liu, Yaqing Liu, Congcong Li, Yi Zhang
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
ABSTRACTAnti-PD-1 antibody therapy has achieved success in tumor treatment; however, the duration of its clinical benefits are typically short. The functional state of intratumoral CD8+ T cells substantially affects the efficacy of anti-PD-1 antibody
Externí odkaz:
https://doaj.org/article/40929eb3d9084be095904ba4d74e9276
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Colorectal cancer (CRC) is the third most common cancer in the world. Although there are standard treatment options for CRC, most patients respond poorly to these treatments. Immunotherapies have gradually emerged due to the increasing awareness and
Externí odkaz:
https://doaj.org/article/8ed788fedc704afca2ba60bdf2d369b1
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Chimeric antigen receptor T (CAR-T) cell therapy is not satisfying in solid tumors. PD-1-mediated suppression greatly hinders CAR-T cells in the microenvironment. It has been shown that PD-1 blockade improves the effectiveness of CAR-T cells. Herein,
Externí odkaz:
https://doaj.org/article/9cd489e249e04be0b677f728a623f8e0
Autor:
Yu Ping, Jiqi Shan, Yaqing Liu, Fengsen Liu, Liuya Wang, Zhangnan Liu, Jieyao Li, Dongli Yue, Liping Wang, Xinfeng Chen, Yi Zhang
Publikováno v:
Cancer Immunology, Immunotherapy. 72:1015-1027
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bba49bf480e5d433700dc4353b4ce73b
https://doi.org/10.1007/s00262-022-03308-z
https://doi.org/10.1007/s00262-022-03308-z
Publikováno v:
Molecular and cellular probes. 62
Studies have shown that patients with lung adenocarcinoma exhibit a poor prognosis, and the overall effective rate of immunotherapy is relatively low. Previous studies reported on the BPIFB2 gene have shown that it participates in immune regulation i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43d69577fd5de15e59aaa02c17a6c2a8
https://pubmed.ncbi.nlm.nih.gov/35240266
https://pubmed.ncbi.nlm.nih.gov/35240266